Concise synthesis and antibacterial evaluation of novel 3-(1,4-disubstituted-1,2,3-triazolyl)uridine nucleosides. 2018

Hamza Tachallait, and Abdelhakim Bouyahya, and Aicha Talha, and Youssef Bakri, and Nadia Dakka, and Luc Demange, and Rachid Benhida, and Khalid Bougrin
Equipe de Chimie des Plantes et de Synthèse Organique et Bioorganique, Faculty of Science, Geophysics, Natural Patrimony and Green Chemistry (GEOPAC) Research Center, Mohammed V University in Rabat, Rabat, Morocco.

We report herein a simple and efficient synthesis of a new series of antibacterial uridine nucleosides. The strategy involved a sequential silylation/N-glycosylation/N-propargylation procedure of uracil 1 for preparing the dipolarophile 5 in good yield. A series of novel uridine-[1,2,3]triazole nucleosides 6a-j were efficiently synthesized via the copper-catalyzed azide-alkyne cycloaddition (CuAAC) from dipolarophile 5 with different selected azides. The reactions were carried out under both conventional and ultrasonic irradiation conditions. In general, improvements were observed when reactions were carried out under sonication. Their antibacterial potential has been evaluated by means of a micro-dilution assay against either Gram-positive or Gram-negative bacteria. Compounds 6i and 6j have shown significant bactericidal activity against Staphylococcus aureus (MIC = 10 and 6 μM, respectively), and 6h against Escherichia coli (MIC = 8 μM). Moreover, antibacterial kinetic assays showed that 6i and 6j significantly reduced the S. aureus growth rate at the MIC concentration, after 6 h, compared to their deprotected analogs, 6k and 6l, respectively. Compound 6h also significantly reduced the growth of E. coli. These antibacterial effects may be related to the penetrating properties of these compounds, as revealed by the leakage of nucleic acids from the sensitive strains.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014529 Uridine A ribonucleoside in which RIBOSE is linked to URACIL. Allo-Uridine,Allouridine,Allo Uridine
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Hamza Tachallait, and Abdelhakim Bouyahya, and Aicha Talha, and Youssef Bakri, and Nadia Dakka, and Luc Demange, and Rachid Benhida, and Khalid Bougrin
January 2021, Natural product research,
Hamza Tachallait, and Abdelhakim Bouyahya, and Aicha Talha, and Youssef Bakri, and Nadia Dakka, and Luc Demange, and Rachid Benhida, and Khalid Bougrin
January 2015, Nucleosides, nucleotides & nucleic acids,
Hamza Tachallait, and Abdelhakim Bouyahya, and Aicha Talha, and Youssef Bakri, and Nadia Dakka, and Luc Demange, and Rachid Benhida, and Khalid Bougrin
October 2023, Chemistry (Weinheim an der Bergstrasse, Germany),
Hamza Tachallait, and Abdelhakim Bouyahya, and Aicha Talha, and Youssef Bakri, and Nadia Dakka, and Luc Demange, and Rachid Benhida, and Khalid Bougrin
November 2014, Journal of medicinal chemistry,
Hamza Tachallait, and Abdelhakim Bouyahya, and Aicha Talha, and Youssef Bakri, and Nadia Dakka, and Luc Demange, and Rachid Benhida, and Khalid Bougrin
January 2018, Current topics in medicinal chemistry,
Hamza Tachallait, and Abdelhakim Bouyahya, and Aicha Talha, and Youssef Bakri, and Nadia Dakka, and Luc Demange, and Rachid Benhida, and Khalid Bougrin
April 2016, Molecules (Basel, Switzerland),
Hamza Tachallait, and Abdelhakim Bouyahya, and Aicha Talha, and Youssef Bakri, and Nadia Dakka, and Luc Demange, and Rachid Benhida, and Khalid Bougrin
May 2012, Medicinal chemistry (Shariqah (United Arab Emirates)),
Hamza Tachallait, and Abdelhakim Bouyahya, and Aicha Talha, and Youssef Bakri, and Nadia Dakka, and Luc Demange, and Rachid Benhida, and Khalid Bougrin
May 2016, Molecules (Basel, Switzerland),
Hamza Tachallait, and Abdelhakim Bouyahya, and Aicha Talha, and Youssef Bakri, and Nadia Dakka, and Luc Demange, and Rachid Benhida, and Khalid Bougrin
November 2010, European journal of medicinal chemistry,
Hamza Tachallait, and Abdelhakim Bouyahya, and Aicha Talha, and Youssef Bakri, and Nadia Dakka, and Luc Demange, and Rachid Benhida, and Khalid Bougrin
April 2019, European journal of medicinal chemistry,
Copied contents to your clipboard!